Basel, Switzerland

Didier Rombach

This inventor holds 1 USPTO granted patent and 3 published patent applications and 5 EPO patents. Top assignee: Hoffmann-La Roche Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Didier Rombach. Retrieved from https://idiyas.com/inventor/didier-rombach-lzs7vdo5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Didier Rombach: Innovator in Medicinal Chemistry

Introduction

Didier Rombach is an accomplished inventor based in Basel, Switzerland. He is currently associated with F. Hoffmann-La Roche AG, a leading global healthcare company. Although he has not yet been granted any patents, his work in medicinal chemistry is noteworthy.

Latest Patent Applications

Didier Rombach has submitted several patent applications that showcase his innovative contributions. One of his latest applications is for "Pyridine Derivatives," which relates to a compound of formula (I) wherein R to R are defined in the description and claims. This compound can be utilized as a medicament. Another significant application is for "Heterocyclic Compounds," which provides new heterocyclic compounds having the general formula (I). The application details compositions including the compounds, processes for manufacturing them, and methods of using these compounds.

Conclusion

Didier Rombach is a promising inventor whose work in the field of medicinal chemistry holds potential for future advancements. His latest patent applications reflect his commitment to innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…